{"schema_version":"1","generated_at":"2026-11-01T06:26:04.093Z","data_as_of":null,"url":"https://www.findmykol.com/kol/lisle-nabell","json_url":"https://www.findmykol.com/kol/lisle-nabell/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"lisle-nabell","name":"Lisle Nabell","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Alabama at Birmingham","institution_url":"https://www.findmykol.com/institution/university-of-alabama-at-birmingham","city":"Birmingham","state":"AL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1700810009","orcid":"0000-0003-0648-5718","openalex":"A5005062075"},"summary":"Lisle Nabell is an Oncology physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 221 publications with 5,916 citations (h-index 31); ClinicalTrials.gov lists 7 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":221,"cited_by_count":5916,"h_index":31,"latest_activity_year":2025,"source":"works"},"trials":{"count":7,"shown":3,"withheld":5,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06105684","title":"Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer","phase":"PHASE2","status":"RECRUITING","role":"Site investigator","sponsor":"University of Alabama at Birmingham","source_url":"https://clinicaltrials.gov/study/NCT06105684","trial_url":"https://www.findmykol.com/trial/NCT06105684"},{"nct":"NCT02837042","title":"Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"University of Alabama at Birmingham","source_url":"https://clinicaltrials.gov/study/NCT02837042","trial_url":"https://www.findmykol.com/trial/NCT02837042"},{"nct":"NCT02541903","title":"Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"University of Alabama at Birmingham","source_url":"https://clinicaltrials.gov/study/NCT02541903","trial_url":"https://www.findmykol.com/trial/NCT02541903"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":3,"shown":3,"withheld":0,"rows":[{"payer":"Gilead Sciences, Inc.","program_year":2025,"amount_usd":19.08,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1700810009"},{"payer":"Seagen Inc.","program_year":2021,"amount_usd":420.67,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1700810009"},{"payer":"Gilead Sciences, Inc.","program_year":2021,"amount_usd":11.92,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1700810009"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1700810009","source":"payments"},"funding":{"award_count":1,"fiscal_years":{"first":2000,"last":2000},"rows_total":2,"shown":2,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"M01RR000032","title":"INTRAVENOUS BCX-34 (PELDESINE) IN REFRACTORY T CELL MALI","fiscal_year":2000,"organization":"UNIVERSITY OF ALABAMA AT BIRMINGHAM","source_url":"https://reporter.nih.gov/quickSearch/M01RR000032"},{"project":"M01RR000032","title":"SGN-15-DOXORUBICIN IMMUNOCONJUGATE &TAXOTERE IN METATASTIC BREAST AND COLORECTAL","fiscal_year":2000,"organization":"UNIVERSITY OF ALABAMA AT BIRMINGHAM","source_url":"https://reporter.nih.gov/quickSearch/M01RR000032"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025","year":2025,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2025.0033","status":"verified"},{"title":"Cardiac Dysfunction Among Breast Cancer Survivors: Role of Cardiotoxic Therapy and Cardiovascular Risk Factors","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.23.01779","status":"verified"},{"title":"Interim Phase II Results Using Panitumumab-IRDye800CW during Transoral Robotic Surgery in Patients with Oropharyngeal Cancer","year":2024,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1078-0432.ccr-24-0940","status":"verified"},{"title":"Traditional risk factors and cancer-related factors associated with cardiovascular disease risk in head and neck cancer patients","year":2023,"journal":"Frontiers in Cardiovascular Medicine","source_url":"https://doi.org/10.3389/fcvm.2022.1024846","status":"verified"},{"title":"Radiotherapy Plus Cisplatin With or Without Lapatinib for Non–Human Papillomavirus Head and Neck Carcinoma","year":2023,"journal":"JAMA Oncology","source_url":"https://doi.org/10.1001/jamaoncol.2023.3809","status":"verified"}],"source":"works"},"contact":{"address_1":"1717 6TH AVE S","city":"Birmingham","state":"AL","zip":"352331801","phone":"800-822-8816","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1700810009","source":"identity"},"similar":[{"name":"Suzanne Oparil","slug":"suzanne-oparil","institution":"University of Alabama at Birmingham","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/suzanne-oparil","json_url":"https://www.findmykol.com/kol/suzanne-oparil/profile.json"},{"name":"Richard Whitley","slug":"richard-whitley","institution":"University of Alabama at Birmingham","specialty":"Pediatric Infectious Diseases","url":"https://www.findmykol.com/kol/richard-whitley","json_url":"https://www.findmykol.com/kol/richard-whitley/profile.json"},{"name":"David Standaert","slug":"david-standaert","institution":"University of Alabama at Birmingham","specialty":"Neurology","url":"https://www.findmykol.com/kol/david-standaert","json_url":"https://www.findmykol.com/kol/david-standaert/profile.json"},{"name":"Bruce Korf","slug":"bruce-korf","institution":"University of Alabama at Birmingham","specialty":"Clinical Genetics (M.D.)","url":"https://www.findmykol.com/kol/bruce-korf","json_url":"https://www.findmykol.com/kol/bruce-korf/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":5,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-06-30","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}